Live feed
Filing
SC 13G
SC 13G0001213900-24-050532·Soleus Capital Master Fund, L.P.
Schedule 13G ownership disclosure
Terns Pharmaceuticals Inc
Security class unavailable · CUSIP: 880881107
Event date: 2024-06-06
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,341,120
- Percent of class
- 5.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-24-050532
- Form type
- SC 13G
- Filer
- Soleus Capital Master Fund, L.P.
- CIK
- CIK 1812275
- Filed
- Jun 07, 2024
- Reporting period
- Jun 06, 2024
- Description
- Schedule 13G beneficial ownership